|
Software to enable applications transparent use of cluster supercomputers |
Acquired |
2005 |
View Profile |
|
Developing a software platform to support the emerging interventional oncology market. |
Private |
2005 |
View Profile |
|
Pioneering the production of Liquid Fuel from the Sun™. |
Private |
2007 |
View Profile |
|
Developing patent-pending UltraClean™ fuels and sustainable chemicals made with the power of synthetic biology. |
Private |
2005 |
View Profile |
|
Developing environmentally sustainable, low cost, low carbon biofuels from cellulosic biomass. |
Private |
2006 |
View Profile |
|
Dedicated to improving healthcare performance and clinical quality |
Private |
2010 |
View Profile |
|
Commercializing chemical catalysts for upgrading waste biomass to fuels, chemicals, and materials. |
Private |
2010 |
View Profile |
|
Pioneering an entirely new drug modality using messenger RNA therapeutics™. |
Private |
2010 |
View Profile |
|
Genetically diverse organisms for agricultural, life science, and pharmaceutical use |
Acquired |
2001 |
View Profile |
|
Pioneering a family of high performance, environmentally responsible polymers and chemical intermediates. |
Private |
2007 |
View Profile |
|
Develops systems to maximize fresh water availability while reducing the energy and cost associated with desalination. |
Private |
2009 |
View Profile |
|
Developmental biology insights for regenerative medicine therapies |
Acquired |
1994 |
View Profile |
|
Pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. |
Private |
2011 |
View Profile |
|
Developer of high-technology purification, analysis and synthesis products |
Acquired |
1991 |
View Profile |
|
Developing novel therapeutics to promote vascular repair. |
Private |
2003 |
View Profile |
|
Transforming global nutrition. |
Private |
2010 |
View Profile |
|
Developing a novel platform for single molecule analysis of proteins. |
Private |
2007 |
View Profile |
|
Developing therapeutic candidates for the treatment of immune and metabolic diseases. |
Public |
2009 |
View Profile |
|
Discovery, development and commercialization of druts to treat neurological diseases and disorders |
Public |
2000 |
View Profile |
|
Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. |
Private |
2005 |
View Profile |